February 12, 2019

First Initiative in Digital Medicine
Notice Regarding the Start of a Demonstration Project for
TOMOCO, a Diabetes Care App

Mitsubishi Tanabe Pharma Corporation (Head Office: Chuo-ku, Osaka; President &Representative Director, CEO: Masayuki Mitsuka) and Habitus Care Inc. (Head Office:Minato-ku, Tokyo; President & Representative Director, CEO: Shinichiro Tokubuchi) haverecently developed TOMOCO, a diabetes care application. The demonstration project forthis application will commence from fiscal 2019. With this app, the two companies will
work together to help address the social issue of diabetes.
In the treatment of diabetes, in addition to diagnosis and treatment at medical
institutions, it is also important for patients to receive appropriate lifestyle guidance
and take steps to address the disease by improving their lifestyle habits, such as in
the areas of food and exercise. The TOMOCO diabetes care app facilitates daily
record-keeping for such information as diet, exercise, medication adherence, blood
sugar levels, etc. and offers follow-up in line with action plans, thereby promotingchanges in patient behavior. In addition, the tracking of daily records, test data, andmedical history data enables the guidance provider to formulate action plans in linewith each patient's issues and motivation.
The aging of Japan's population continues to accelerate, and measures to control
healthcare expenditures have become an important issue in the domestic
healthcare environment. The focus of government healthcare policy is shifting fromtreatment to prevention, and awareness of individual health management isincreasing. In particular, with diabetes, which is a lifestyle-related disease, the risein healthcare expenditures related to the use of dialysis has become a major
problem, and preventing the progression of diabetes to a severe condition is now asocial issue. In this environment, the government has launched a grant for
supporting insurers service, HOKENJA-DORYOKU-SHIEN program, that supports
initiatives by municipalities (national health insurance) to prevent the progression ofdiabetes to a severe condition, and municipalities recommend consultations at
medical institutions and provide health guidance for improvement of lifestyle habits.

1 / 2

Plans call for the TOMOCO diabetes care app to be utilized as a part of healthpromotion activities advanced by insurers, such as national health insurance andhealth insurance associations. Currently, partners are being recruited for thedemonstration project, such as insurers and municipalities, and plans call for anexhibit at the Regional Comprehensive Care Expo Osaka, which will be held at
Intex Osaka on February 20 to 22.
Under the Medium-Term Management Plan 16-20 Open Up the Future, Mitsubishi
Tanabe Pharma is advancing the expansion of drug discovery opportunities usingmodalities (utilizing new modalities) and actively working not only withconventional small molecules and antibodies but also with digital medicine
initiatives that leverage digital technologies. The TOMOCO diabetes care app will
be a first initiative in digital medicine.
Mitsubishi Tanabe Pharma Corporation,
Corporate Communications Department
Media contacts:TEL: +81 6 6205 5119
Investors contacts:TEL: +81 6 6205 5110
Business-related consultations
Mitsubishi Tanabe Pharma Corporation, Future Design Department
For further information, please contact:
Business-related consultations

TEL: +81 6 6205 5373

<Reference>■About Habitus Care Inc.
Habitus Care Inc. is a healthcare venture that aims to promote the health ofconsumers and to help resolve social issues through support services, backed byleading scientific research, that aim to prevent the development of disease andthe progression of disease to a severe condition.
In cooperation with medical and pharmaceutical researchers and other healthcare
professionals, such as at the University of Tokyo; the Faculty of Medicine at theUniversity of Tsukuba; and Ochanomizu University, Habitus Care is working todevelop and provide services for companies and municipalities, and to use thatknowledge to support the development of new businesses and services in thehealthcare field.

2 / 2